COMMUNIQUÉS West-GlobeNewswire

Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
03/08/2026
REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the [...]
CapsoVision® Announces International Launch of AI Highlights
03/08/2026
AI-assisted review feature designed to support physician review of small bowel capsule endoscopy studies using the CapsoCam Plus® system SARATOGA, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV [...]
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
03/08/2026
August 3, 2026 – 22:01 PM CEST Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company committed to improving the lives of people suffering from severe autoimmune [...]
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 2 newly- [...]
Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference
03/08/2026
REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the [...]
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
03/08/2026
ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected strong [...]
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
03/08/2026
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral [...]
HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule
03/08/2026
DRAPER, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in [...]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on August 1, 2026, the Compensation [...]
Vireo Growth to Report Second Quarter 2026 Financial Results on August 11, 2026
03/08/2026
MINNEAPOLIS, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that the Company will host a conference call on Tuesday, August 11, 2026, at 8:00 a [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
REACT19 Launches $100,000 Matching Campaign as Demand for Medical Grants Surges 33%
03/08/2026
Six families need help today. Fifteen more are already waiting. Every donation through September will be doubled to provide life-saving medical care MEQUON, Wisc., Aug. 03, 2026 (GLOBE NEWSWIRE) -- REACT19 today [...]
A Race Against Blindness Launches New Research Grants Program to Accelerate Treatments for Inherited Retinal Diseases and Bardet-Biedl Syndrome
03/08/2026
New grant program announced at the Bardet-Biedl Syndrome Foundation Annual Conference invites researchers worldwide to apply for funding GILBERT, Ariz., Aug. 03, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness today [...]
The Ferrari Foundation Advances Fifth Annual Adam Ferrari Health Science Scholarship to Finalist Review
03/08/2026
Three finalists will be selected for the $20,000 scholarship before the recipient is announced on September 1 IRVINE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Ferrari Foundation has begun the finalist selection [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 31 - 2026
03/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 27 juillet au 31 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2026
03/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 27th July to 31st July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument [...]
Carbios provides an update on the financing of its Longlaville plant project
03/08/2026
Carbios reaffirms its commitment to building the Longlaville plant. Significant milestones have been achieved toward securing the project’s financing. While significant progress has been made, the previously announced [...]
Carbios fait un point d’étape sur le financement de son projet d’usine à Longlaville
03/08/2026
Carbios réaffirme son ambition de construction de l’usine de Longlaville Des étapes importantes en vue de la sécurisation du financement du projet ont été franchies L’objectif annoncé d’un closing d’ici le 30 septembre [...]
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
03/08/2026
Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]

Pages